logo-loader

Tessco reports weak Q3 results, guides for gloomy Q4

Published: 11:42 26 Jan 2016 EST

1-19505009639_baa08d8bf5_o
Tessco delivers product and value chain solutions to support wireless systems.

Tessco Technologies (NASDAQ:TESS) fell in morning trading after the wireless communications company reported lower-than-expected results in its third quarter and cut its outlook.

Shares dropped 8.7% to $18.07 at 10:55 a.m. in New York, expanding losses over the past year to 22%.

Net income rose to $2.9mln, or $0.35 per diluted share, in the three months ended December 27, from 1.7mln, or $0.20 per diluted share, in the year-earlier period, the Hunt Valley, Maryland-based company said in a statement late on Monday.

That lagged behind the Capital IQ consensus of $0.36 per share.

Q3 revenue rose to $139.5mln from $135.2mln year-over-year, missing predictions for $150.39mln.

Tessco expects full-year earnings to be $0.76 to $0.94 per share.

“As the third quarter progressed, and we entered the fourth quarter which is traditionally our weakest quarter for both revenues and earnings, we have seen increased purchasing hesitancy in all of our markets due to global economic concerns,” CEO Robert Barnhill said in the statement.

“We also expect recent weather events to temporarily hamper sales.”

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

2 hours, 51 minutes ago